Metoject Pen 15 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 15 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 15 mg solution for injection in pre-filled pen

Metoject Pen 17,5 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 17,5 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 17,5 mg solution for injection in pre-filled pen

Metoject Pen 20 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 20 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 20 mg solution for injection in pre-filled pen

Metoject Pen 22,5 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 22,5 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 22,5 mg solution for injection in pre-filled pen

Metoject Pen 25 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 25 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 25 mg solution for injection in pre-filled pen

Metoject Pen 27,5 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 27,5 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 27,5 mg solution for injection in pre-filled pen

Metoject Pen 30 mg solution for injection in pre-filled Pen Bugarska - bugarski - Изпълнителна агенция по лекарствата

metoject pen 30 mg solution for injection in pre-filled pen

medac gesellschaft fur klinische spezialpraparate mbh - 30 mg solution for injection in pre-filled pen

Jylamvo Europska Unija - bugarski - EMA (European Medicines Agency)

jylamvo

therakind (europe) limited - Метотрексат - arthritis, psoriatic; precursor cell lymphoblastic leukemia-lymphoma; psoriasis; arthritis, rheumatoid; arthritis - Антинеопластични средства - В ревматологические и дерматологични diseasesactive ревматоиден артрит при възрастни пациенти. polyarthritic форми на активна, тежка ювенильного идиопатического артрит (ЮИА) при юноши и деца на възраст под 3 години и повече, когато реакцията на нестероидни противовъзпалителни средства (НСПВС), е неадекватна.. Упорита, лечението е тугоплавкий, изключване на псориазис, които не е достатъчно да отговори на други форми на лечение, като фототерапия, псоралена и на ултравиолетова радиация (ПУВА) терапия и ретиноиди и тежък псориатичен артрит при възрастни пациенти. В oncologymaintenance лечение на остър лимфобластного левкемия (ол) при възрастни, юноши и деца на възраст под 3 години и по-възрастни.

Nordimet Europska Unija - bugarski - EMA (European Medicines Agency)

nordimet

nordic group b.v. - Метотрексат - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - Антинеопластични средства - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Methotrexate Accord 100 mg/ml concentrate for solution for infusion Bugarska - bugarski - Изпълнителна агенция по лекарствата

methotrexate accord 100 mg/ml concentrate for solution for infusion

100 mg/ml concentrate for solution for infusion